In situ activation and heterologous production of a cryptic lantibiotic from a plant-ant derived Saccharopolyspora species
In situ activation and heterologous production of a cryptic lantibiotic from a plant-ant derived Saccharopolyspora species
复制标题
来自植物蚂蚁来源的糖多孢菌物种的隐性羊毛硫抗生素的原位激活和异源生产
DOI:
10.1101/733808
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Vikeli E
中科院分区:
文献类型:
--
作者:
Vikeli E
Most clinical antibiotics are derived from actinomycete natural products discovered at least 60 years ago. However, the repeated rediscovery of known compounds led the pharmaceutical industry to largely discard microbial natural products (NPs) as a source of new chemical diversity. Recent advances in genome sequencing have revealed that these organisms have the potential to make many more NPs than previously thought. Approaches to unlock NP biosynthesis by genetic manipulation of strains, by the application of chemical genetics, or by microbial cocultivation have resulted in the identification of new antibacterial compounds. Concomitantly, intensive exploration of coevolved ecological niches, such as insect-microbe defensive symbioses, has revealed these to be a rich source of chemical novelty. Here, we report the new lanthipeptide antibiotic kyamicin, which was generated through the activation of a cryptic biosynthetic gene cluster identified by genome miningSaccharopolysporaspecies found in the obligate domatium-dwelling ant Tetraponera penzigi of the ant plant Vachellia drepanolobium. Transcriptional activation of this silent gene cluster was achieved by ectopic expression of a pathway-specific activator under the control of a constitutive promoter. Subsequently, a heterologous production platform was developed which enabled the purification of kyamicin for structural characterization and bioactivity determination. This strategy was also successful for the production of lantibiotics from other genera, paving the way for a synthetic heterologous expression platform for the discovery of lanthipeptides that are not detected under laboratory conditions or that are new to nature.IMPORTANCEThe discovery of novel antibiotics to tackle the growing threat of antimicrobial resistance is impeded by difficulties in accessing the full biosynthetic potential of microorganisms. The development of new tools to unlock the biosynthesis of cryptic bacterial natural products will greatly increase the repertoire of natural product scaffolds. Here, we report a strategy for the ectopic expression of pathway-specific positive regulators that can be rapidly applied to activate the biosynthesis of cryptic lanthipeptide biosynthetic gene clusters. This allowed the discovery of a new lanthipeptide antibiotic directly from the native host and via heterologous expression.
登录
查看更多内容
影响因子:
3.4
作者:
Seipke, Ryan F.;Barke, Joerg;Heavens, Darren;Yu, Douglas W.;Hutchings, Matthew I.
通讯作者:
Hutchings, Matthew I.
影响因子:
15
作者:
Odette L. Shotwell;F. Stodola;William R. Michael;L. A. Lindenfelser;R. G. Dworschack;T. G. Pridham
通讯作者:
T. G. Pridham
影响因子:
46.2
作者:
Ethan B. Van Arnam;C. Currie;J. Clardy
通讯作者:
Ethan B. Van Arnam;C. Currie;J. Clardy
影响因子:
3.4
作者:
Iwamoto, Kunihiko;Hayakawa, Tomohiro;Kobayashi, Toshihide
通讯作者:
Kobayashi, Toshihide
影响因子:
11.9
作者:
Arnison PG;Bibb MJ;Bierbaum G;Bowers AA;Bugni TS;Bulaj G;Camarero JA;Campopiano DJ;Challis GL;Clardy J;Cotter PD;Craik DJ;Dawson M;Dittmann E;Donadio S;Dorrestein PC;Entian KD;Fischbach MA;Garavelli JS;Göransson U;Gruber CW;Haft DH;Hemscheidt TK;Hertweck C;Hill C;Horswill AR;Jaspars M;Kelly WL;Klinman JP;Kuipers OP;Link AJ;Liu W;Marahiel MA;Mitchell DA;Moll GN;Moore BS;Müller R;Nair SK;Nes IF;Norris GE;Olivera BM;Onaka H;Patchett ML;Piel J;Reaney MJ;Rebuffat S;Ross RP;Sahl HG;Schmidt EW;Selsted ME;Severinov K;Shen B;Sivonen K;Smith L;Stein T;Süssmuth RD;Tagg JR;Tang GL;Truman AW;Vederas JC;Walsh CT;Walton JD;Wenzel SC;Willey JM;van der Donk WA
通讯作者:
van der Donk WA